| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/17/2005 | WO2005014798A2 Novel compositions and methods for promoting, inhibiting, and detecting protein entry into cells |
| 02/17/2005 | WO2005014639A2 Periodic antimicrobial peptides |
| 02/17/2005 | WO2005014625A1 Polypeptides having brain disposition activity and utilization of the same |
| 02/17/2005 | WO2005014624A2 Preparation of somatostatin peptides |
| 02/17/2005 | WO2005014617A2 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 02/17/2005 | WO2005014615A2 Self-assembling peptides incorporating modifications and methods of use thereof |
| 02/17/2005 | WO2005014030A1 Method for treating lung diseases associated with ventilation-perfusion mismatches |
| 02/17/2005 | WO2004099135A3 Hiv prodrugs cleavable by cd26 |
| 02/17/2005 | WO2004083236A3 Cancer treatment using proanp peptides |
| 02/17/2005 | US20050038234 Bi-functionalised metallocenes use for marking biological molecules |
| 02/17/2005 | US20050038233 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight |
| 02/17/2005 | US20050038230 For decreasing food intake; eating disorders; sexual disorders |
| 02/17/2005 | US20050038228 Makes it possible to selectively adsorb an immunoglobulin and/or an immune complex present in a body fluid (for example, blood, plasma, etc.) efficiently without pretreating the body fluid |
| 02/17/2005 | US20050038019 Hydroxy substituted amides for the treatment of alzheimer's disease |
| 02/17/2005 | US20050037971 Use of hepcidin as a regulator of iron homeostasis |
| 02/17/2005 | US20050037959 Low white blood cell titer |
| 02/17/2005 | US20050037951 Composition and methods for treatment of sexual dysfunction |
| 02/17/2005 | US20050037950 N1-modified glycopeptides |
| 02/17/2005 | US20050037430 creating a peptide database by screening, analyzing the results, characterizing a physical, chemical, or biological property of the peptides, recording; using a computer for presenting biomolecular sequence data; regulatory activity on pro- or anti-inflammatory cytokine cascades; immunoresponse |
| 02/17/2005 | US20050036980 cell adhesion promoting (CAP) peptide combinations that promote cell attachment or cell adhesion to culture surfaces that are otherwise cell adhesion resistant CAR); peptides when coupled to a CAR layer such as hyaluronic acid that has been created on a polymer surface, promote cell growth |
| 02/17/2005 | US20050036948 Radiolabeled annexins |
| 02/17/2005 | CA2534899A1 Polypeptides having brain-localizing activity and uses thereof |
| 02/17/2005 | CA2534708A1 Targeted carrier fusions for delivery of chemotherapeutic agents |
| 02/17/2005 | CA2530482A1 Self-assembling peptides incorporating modifications and methods of use thereof |
| 02/16/2005 | EP1506312A2 Metalloprotease peptide substrates and methods |
| 02/16/2005 | EP1506221A2 Fap-activated anti-tumor prodrugs |
| 02/16/2005 | EP1506220A1 Antagonistic peptides of prostaglandin e2 receptor subtype ep4 |
| 02/16/2005 | EP1506218A2 Reversible modification of membrane interaction |
| 02/16/2005 | EP1506018A1 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s) |
| 02/16/2005 | EP1037906B1 Cyclopeptide derivatives with integrin inhibitor properties |
| 02/16/2005 | CN1582301A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/16/2005 | CN1582296A Template-fixed peptidomimeticsas inhibitors of serine proteases |
| 02/16/2005 | CN1189478C Cyclic compound |
| 02/16/2005 | CN1189477C Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition |
| 02/16/2005 | CN1189209C Application of osteogenic growth peptide in promoting bematogenesis |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/15/2005 | US6855810 Ligands directed to the non-secretory component, non-stalk region of plgR and methods of use thereof |
| 02/15/2005 | US6855801 Peptides modulating activities of heparin other glycosaminoglycans or proteoglycans |
| 02/15/2005 | US6855692 Histogranin peptides and their analgesic use |
| 02/15/2005 | US6855689 Anticancer agents |
| 02/15/2005 | US6855528 Administering a covalently reactive antigen analog (CRAA) having an an epitope recognized irreversibly bound by catalytic antibody; autoimmune disease; a lymphoproliferative disorder; anticarcinogenic, -tumor, -inflammatory agents |
| 02/10/2005 | WO2005012541A1 Method for producing cyclic molecules |
| 02/10/2005 | WO2005012502A2 Methods of identifying optimal variants of peptide epitopes |
| 02/10/2005 | WO2005012348A2 Cyclic cadherin analogues comprising the sequence hav for modulating the migration of vascular smooth muscle cells |
| 02/10/2005 | WO2005012335A1 Imaging agents |
| 02/10/2005 | WO2005012329A2 Kinase and phosphatase assays |
| 02/10/2005 | WO2005012247A1 Compounds and methods for the rapid quantitative analysis of proteins and polypeptides |
| 02/10/2005 | WO2005011607A2 Treatment of cancers expressing p95 erbb2 |
| 02/10/2005 | WO2004104030A3 Peptides modulating the activity of the engrailed transcription factor |
| 02/10/2005 | US20050032707 Novel peptides comprising furanoid sugar amino acids for the treatment of cancer |
| 02/10/2005 | US20050032706 Hypoglycaemic peptides and methods of use thereof |
| 02/10/2005 | US20050032704 Neural thread proteins (NTP); antiproliferative agents |
| 02/10/2005 | US20050032688 Use of angiotensin II fragments and analogs thereof in tissue repair |
| 02/10/2005 | US20050032684 Use of a peptide which activates guanylate-cyclase c for the treatment of respiratory airway problems via the airways, medicament, inhaltion devices and method of diagnosis |
| 02/10/2005 | US20050032679 Process for the preparation of echinocandin derivatives |
| 02/10/2005 | US20050032190 Beta-secretase substrates and uses thereof |
| 02/10/2005 | US20050032131 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 02/10/2005 | US20050032107 Method of screening anti-mycobacterial molecules |
| 02/10/2005 | US20050032047 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay |
| 02/10/2005 | US20050031635 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen |
| 02/10/2005 | US20050031604 Secreted by serpent venom glands; endogenous vasopeptidase inhibitors; angiotensin converting enzyme inhibitors; vasodilating and anti-hypertensive action; bradykinins; mass spectrometry |
| 02/10/2005 | US20050031542 using carbocyanine dyes; photodynamic therapy; supplying to tumors |
| 02/10/2005 | DE10156995A1 New peptide compounds containing upto 6 aminoacid residues, are potent and specific thrombin inhibitors used for treating and diagnosing diseases associated with thrombin |
| 02/10/2005 | CA2574733A1 Method for the production of cyclic molecules |
| 02/10/2005 | CA2533781A1 Cyclic cadherin analogues comprising the sequence hav for modulating the migration of vascular smooth muscle cells |
| 02/10/2005 | CA2520768A1 Methods of identifying optimal variants of peptide epitopes |
| 02/09/2005 | EP1504094A2 Peptide compounds and their use as protease substrates |
| 02/09/2005 | EP1504022A2 Process for the synthesis of peptide amides by side-chain attachment to a solid phase |
| 02/09/2005 | EP1503792A2 Attenuation of metapneumovirus |
| 02/09/2005 | EP1503767A2 Compositions and methods for treatment of vitamin d deficiency |
| 02/09/2005 | EP1503749A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 02/08/2005 | US6852700 Colostrinin, and uses thereof |
| 02/08/2005 | US6852699 Effective content of one or more monomeric or homo- or heterodimeric or homo- or heterotrimeric or homo- or heterotetrameric oligopeptides, where these oligopeptides are based on a structure Val-Val-Arg-Pro as homo- or |
| 02/08/2005 | US6852697 Peptides for treatment of inflammation and shock |
| 02/08/2005 | US6852696 Inhibitors of glycosaminoglycans |
| 02/08/2005 | US6852695 For therapy of hyperglycemic disorders |
| 02/08/2005 | US6852693 Compositions and methods for promoting lipid mobilization in humans |
| 02/03/2005 | WO2005010031A1 Peptides capable of binding to titanium, silver and silicone |
| 02/03/2005 | WO2005010030A2 C5a receptor antagonists |
| 02/03/2005 | WO2005010027A2 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 02/03/2005 | WO2005010024A2 Potent peptide inhibitors and methods of use |
| 02/03/2005 | WO2005009948A2 Peptide inhibitors of beta-lactamases |
| 02/03/2005 | WO2005009366A2 Restoring vascular function |
| 02/03/2005 | WO2005009363A2 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 02/03/2005 | WO2005009217A2 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 02/03/2005 | WO2004106366A8 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 02/03/2005 | WO2004031722A3 Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr) |
| 02/03/2005 | WO2002096360A3 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 02/03/2005 | US20050027457 Biosynthesis of amino acid sequences; rearrangement of peptide; ; |
| 02/03/2005 | US20050027105 Multimeric proteins for use in the treatment and detection of cell proliferative disorders |
| 02/03/2005 | US20050026843 Organic compounds with biological activity as thrombin inhibitors and use thereof |
| 02/03/2005 | US20050026841 Hab18g/cd147 its antagonist and application |
| 02/03/2005 | US20050026840 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or pertidomimetics |
| 02/03/2005 | US20050026827 Octapeptide bombesin analogs |
| 02/03/2005 | US20050026818 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/03/2005 | US20050025821 Lipid-comprising drug delivery complexes and methods for their production |
| 02/03/2005 | US20050025784 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 02/03/2005 | DE10146632A1 New peptide compounds containing upto 6 aminoacid residues, are potent and specific thrombin inhibitors used for treating and diagnosing diseases associated with thrombin |
| 02/03/2005 | CA2532994A1 C5a receptor antagonists |
| 02/03/2005 | CA2532869A1 Novel peptidic conjugates for alopecia preventive and curative treatment |